Urological Drug Price Stewardship: Potential Cost Savings Based on the Mark Cuban Cost Plus Drug Company Model

J Urol. 2023 Feb;209(2):309-311. doi: 10.1097/JU.0000000000003083. Epub 2022 Nov 22.
No abstract available

Keywords: Medicare Part D; drug costs; drug prescriptions; drugs, generic; health policy.

Publication types

  • Editorial

MeSH terms

  • Cost Savings
  • Drug Costs*
  • Drug Prescriptions*
  • Humans
  • United States